Skip to content

The effect of diet intervention and MAFcapsules on congnitve function in elderly peopleusing outpatiant rehabilitation

The effect of diet and macrophage activation factor on cognitive function in eldely outopatiant rehabilitation: randomized control trial - The effect of diet and MAF on cognitive function in eldely outopatiant rehabilitation: randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050155
Enrollment
60
Registered
2023-01-27
Start date
2022-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly persons using day rehabilitation facilities

Interventions

Dietary guidance (after detailed interviews, provide guidance on a diet with a low inflammation index to the extent possible) plus placebo (2 capsles per day) Dietary guidance + MAF capsules taken (

Sponsors

Saisei Immunotherapy Clinics
Lead Sponsor
So-Shin-Kai Cop.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 65 years of age or older 2) Those who have been using an outpatient rehabilitation facility 3) Those who have been attending the facility for more than 3 months and whose condition is stable.

Exclusion criteria

Exclusion criteria: 1) Cases in which the subject has been diagnosed with severe anemia, terminal cancer, Parkinson's disease or other degenerative brain disease 2) Cases in which the research subject requests withdrawal of consent 3) When it becomes impossible to comply with the research protocol (4) When the entire research is terminated (5) Other cases in which the principal investigator or a subinvestigator determines that it is difficult to continue the research.

Design outcomes

Primary

MeasureTime frame
Cognitive function tests: MCI Screen (Mild Cognitive Impairment)

Secondary

MeasureTime frame
1) Degree of senescence: AGE value 2) Plasma amyloid beta 40/42 ratio 3) General blood collection: blood count, hemogram, ferritin, folic acid, vitamin B12, B1, CRP, HbA1c, 1/5 AG, fT4, TSH, GOT, GPT, ALB, BUN, Cr, Na, K, Cl, Zn, Cu, 1,25-(OH)VitD

Countries

Japan

Contacts

Public ContactYoko Uchiyama

Yoko-Clinic none

yoko-uchiyama-tanaka@yoko-clinic.net093-651-0880

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026